The Characteristics of Rare Diseases That Complicate the Assessment of Technology Value
Автор: Health Technology Assessment international - HTAi
Загружено: 2024-02-29
Просмотров: 726
Описание:
This HTAi Webinar is hosted by the HTAi Rare Diseases Interest Group.
Evaluating the value of rare disease technologies poses challenges due to factors like poor natural history, small populations, limited data, complexity, and high unmet needs. Challenges vary across the spectrum of ultra-rare to more prevalent diseases, with added complexities in different populations, such as pediatrics. This webinar aims to highlight these characteristics, elucidate their role in hindering evidence generation and value assessment, and discuss the resulting difficulties in obtaining approvals. The session will also outline the impact of these challenges and detail the strategies planned by the Rare Disease Interest group to address and overcome them.
Panelists:
Elena Nicod – Director, Dolon | Italy
Fleur Chandler – Head of Market Access UK and Ireland, Sanofi | United Kingdom
Dan Ollendorf – Chief Scientific Officer and Director of Health Technology Assessment Methods and Engagement, ICER | United States of America
Karen Facey – Independent | United Kingdom
Sheela Upadhyaya – Life Sciences Consultant, Independent | United Kingdom
This webinar was held February 27, 2024.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
